BriaCell Therapeutics Corp. Quarterly Return On Equity in % from Q1 2023 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BriaCell Therapeutics Corp. quarterly/annual Return On Equity history and growth rate from Q1 2023 to Q2 2024.
  • BriaCell Therapeutics Corp. Return On Equity for the quarter ending July 31, 2024 was 130 %, a 99% decline year-over-year.
  • BriaCell Therapeutics Corp. annual Return On Equity for 2024 was 130 %, a 99% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 130 -13.1K -99% May 1, 2024 Jul 31, 2024
Q1 2024 152 +695 Feb 1, 2024 Apr 30, 2024
Q4 2023 326 Nov 1, 2023 Jan 31, 2024
Q3 2023 626 Aug 1, 2023 Oct 31, 2023
Q2 2023 13.2K May 1, 2023 Jul 31, 2023
Q1 2023 -544 Feb 1, 2023 Apr 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.